arkaytherapeutics.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
# Robots.txt file from http://www.arkaytherapeutics.com Sitemap: http://www.arkaytherapeutics.com/sitemap.xml User-agent: *
Meta Tags
Title Type 2 diabetes Company, novel beta cell centric product ARKAY
Description TriGlytza™: A Patient-Centric Think-Outside-The-Box Approach For Treating Type 2 (609) 362-6818 Follow Us: Home Our Approach Investors Our Team News Career Publications Contact Forefront of Modern Innovative Medicine --> --> --&g
Keywords N/A
Server Information
WebSite arkaytherapeutics faviconarkaytherapeutics.com
Host IP 206.188.192.1
Location United States
Related Websites
Site Rank
More to Explore
arkaytherapeutics.com Valuation
US$2,632,438
Last updated: 2023-05-13 00:50:19

arkaytherapeutics.com has Semrush global rank of 4,020,724. arkaytherapeutics.com has an estimated worth of US$ 2,632,438, based on its estimated Ads revenue. arkaytherapeutics.com receives approximately 303,743 unique visitors each day. Its web server is located in United States, with IP address 206.188.192.1. According to SiteAdvisor, arkaytherapeutics.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$2,632,438
Daily Ads Revenue US$2,430
Monthly Ads Revenue US$72,899
Yearly Ads Revenue US$874,780
Daily Unique Visitors 20,250
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
arkaytherapeutics.com. A 7200 IP: 206.188.192.1
arkaytherapeutics.com. NS 7200 NS Record: ns64.worldnic.com.
arkaytherapeutics.com. NS 7200 NS Record: ns63.worldnic.com.
arkaytherapeutics.com. MX 7200 MX Record: 10 mx.myregisteredsite.com.
arkaytherapeutics.com. TXT 7200 TXT Record: v=spf1 include:spf.registeredsite.com ~all
HtmlToTextCheckTime:2023-05-13 00:50:19
(609) 362-6818 Follow Us: Home Our Approach Investors Our Team News Career Publications Contact Forefront of Modern Innovative Medicine --> --> --> --> --> Human proof-of-concept (PoC): Immunofluorescence with Cox-2 (red) and DAPI (blue). Cox-2 is elevated in pancreatic islets of Type 2 diabetes (T2DM) patients compared to human islets isolated from patients without T2DM (ND). Mission Statement Change The Current Type 2 Diabetes Disease Trajectory of Failure Of First, Second And Third Line of Therapies, Clinical Inertia, Insulin Dependence and Diabetes Complications Recent Press Releases February 20, 2019 | ARKAY Therapeutics Announced as a Finalist in Most Successful Early Phase Research in 2019 Clinical & Research Excellence Awards June 5, 2018 | The U.S. FDA Approves ARKAY Therapeutics’ IND Application for Evaluating RK-01, a First-in-Class ‘Beta-cell-centric’ Drug Combination Product in Type 2 Diabetes Patients Click to Enlarge TriGlytza™: A Patient-Centric
HTTP Headers
HTTP/1.1 301 Moved Permanently
Server: openresty/1.19.9.1
Date: Mon, 20 Dec 2021 09:09:39 GMT
Content-Type: text/html; charset=iso-8859-1
Content-Length: 241
Connection: keep-alive
Location: http://www.arkaytherapeutics.com/
X-Webcom-Cache-Status: BYPASS

HTTP/1.1 200 OK
Server: openresty/1.19.9.1
Date: Mon, 20 Dec 2021 09:09:40 GMT
Content-Type: text/html
Content-Length: 176348
Connection: keep-alive
Vary: Accept-Encoding
Last-Modified: Mon, 18 Oct 2021 19:12:18 GMT
ETag: "2b0dc-5cea552d34b6e"
X-Webcom-Cache-Status: BYPASS
Accept-Ranges: bytes
arkaytherapeutics.com Whois Information
Domain Name: ARKAYTHERAPEUTICS.COM
Registry Domain ID: 1869670547_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2021-06-05T09:05:59Z
Creation Date: 2014-08-04T18:57:41Z
Registry Expiry Date: 2022-08-04T18:57:41Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS63.WORLDNIC.COM
Name Server: NS64.WORLDNIC.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-12-23T07:27:59Z <<<